![]() |
市場調査レポート
商品コード
1792383
癒着防止材の市場レポート:製品別、製剤別、用途別、地域別、2025~2033年Adhesion Barriers Market Report by Product, Formulation, Application, and Region 2025-2033 |
||||||
カスタマイズ可能
|
癒着防止材の市場レポート:製品別、製剤別、用途別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の癒着防止材の市場規模は、2024年に11億1,270万米ドルに達しました。IMARC Groupは、市場は2033年までに19億320万米ドルに達し、2025~2033年の成長率(CAGR)は5.84%になると予測しています。心臓血管外科、再建外科、泌尿器科手術などにおけるフィルムベースの医療用インプラントの用途拡大が市場を強化しています。
外科手術の増加
婦人科疾患、心血管疾患、整形外科疾患など、手術を必要とする疾患の罹患率の増加が市場を活性化しています。さらに、痛みや合併症、追加手術の原因となる瘢痕組織の形成を抑える必要性が高まっていることも、成長を促す重要な要因となっています。例えば、2024年4月、FzioMed, Inc.は、イタリアのローマで開催されたHysteroscopy, Assisted Reproductive Technology, and Ultrasound(HARTUS)会議で、腹腔鏡および子宮鏡手術後の癒着形成を最小限に抑えるように設計された革新的なOxiplex癒着防止ゲル製品ポートフォリオを展示しました。これが癒着防止材市場の需要を高めています。
技術的進歩の増加
生体吸収性材料の改良とともに、生物製剤の採用が増加していることが市場を刺激しています。生体吸収性材料は、炎症反応の低減、組織適合性の向上、外科手術時の適用が容易です。例えば、2024年2月、ハーバード大学のWyss Institute for Biologically Inspired Engineeringの科学者たちは、キトサンの薄いフィルムを使用して、同じまたは異なるタイプのハイドロゲルや他の高分子材料でできた層を効果的に接着する汎用的で簡単な方法を開発しました。
新規治療の増加
医療費の増大が市場を強化しています。また、ヘルスケアサービスへのアクセス向上への注目が高まっていることも、市場に明るい展望をもたらしています。例えば、2024年5月、Radboud University Medical Centerの3つのプロジェクトが、ZonMWとKCEの協力によるBeNeFITプログラムから資金提供を受けました。この3つのプロジェクトはすべて、ベルギーとオランダの複数の病院で実施される大規模な臨床研究に関わるものです。これらの研究は、精神科、外科、集中治療に焦点を当てています。
The global adhesion barriers market size reached USD 1,112.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,903.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.84% during 2025-2033. The increasing applications of these film-based medical implants in cardiovascular, reconstructive, and urological surgeries are bolstering the market.
Growing Surgical Procedures
The increasing incidence of conditions requiring surgery, such as gynecological, cardiovascular, and orthopedic disorders, is catalyzing the market. Moreover, the inflating need for reducing the formation of scar tissue that can lead to pain, complications, and additional surgeries is also acting as another significant growth-inducing factor. For example, in April 2024, FzioMed, Inc. showcased its innovative Oxiplex adhesion barrier gel product portfolio designed to minimize the formation of post-surgical adhesions following laparoscopic and hysteroscopic surgery at Hysteroscopy, Assisted Reproductive Technology, and Ultrasound (HARTUS) congress in Rome, Italy. This is escalating the adhesion barriers market demand.
Increasing Technological Advancements
The rising adoption of biologics, along with the improvements in bioresorbable materials, are stimulating the market. They offer reduced inflammatory responses, better tissue compatibility, and easier application during surgical procedures. For instance, in February 2024, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard created a versatile and simple method to effectively bond layers made of the same or different types of hydrogels and other polymeric materials using a thin film of chitosan, which is expanding adhesion barriers market share.
Rising Novel Medical Treatment
The inflating healthcare expenditure capacities are strengthening the market. Apart from this, the increasing focus on providing better access to healthcare services is further providing a positive outlook to the market. For example, in May 2024, three projects from Radboud University Medical Center received funding from the BeNeFIT program, a collaboration between ZonMW and KCE. All three projects involve major clinical studies conducted in several hospitals across Belgium and the Netherlands. These studies focus on psychiatry, surgery, and intensive care.
Synthetic dominates the market
Synthetic adhesion barriers represent engineered materials that prevent post-surgical adhesions. One such example is REPEL-CV, a bioresorbable adhesion barrier designed for utilization in cardiovascular surgeries, which is increasing the adhesion barriers market outlook.
The film holds the majority of the global adhesion barriers market revenue
Film adhesion barriers are aimed at improving efficacy and patient outcomes. A significant launch is the GYNECARE INTERCEED absorbable adhesion barrier.
Gynecological surgeries dominate the adhesion barriers market statistics
The rising focus on preventing the formation of adhesions that can lead to complications is driving the segment's growth. PREVADH(R) absorbable adhesion barrier introduced by FzioMed is gaining extensive traction, as it is easy to handle.
North America exhibits a clear dominance in the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the adhesion barriers market overview, the widespread surgical procedures are acting as significant growth-inducing factors. For example, the REPEL-CV adhesion barrier by SyntheMed is specifically designed for cardiovascular surgeries.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major adhesion barriers market companies have also been provided. Some of the key players in the market include: